[1. Driggin E, Madhavan MV, Bikdeli B, et al. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic. J Am Coll Cardiol. 2020;75:2352-2371.10.1016/j.jacc.2020.03.031719885632201335]Search in Google Scholar
[2. Guarner J. Three Emerging Coronaviruses in Two Decades. Am J Clin Pathol. 2020;153:420-421.10.1093/ajcp/aqaa029710969732053148]Search in Google Scholar
[3. Sardu C, Gambardella J, Morelli MB, Wang X, Marfella R, Santulli G. Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence. J Clin Med. 2020;9:1417.10.3390/jcm9051417729076932403217]Search in Google Scholar
[4. Giannis D, Ziogas IA, Gianni P. Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past. J Clin Virol. 2020;127:104362.10.1016/j.jcv.2020.104362719527832305883]Search in Google Scholar
[5. Danzi GB, Loffi M, Galeazzi G, Gherbesi E. Acute pulmonary embolism and COVID-19 pneumonia: a random association?. Eur Heart J. 2020;41:1858.10.1093/eurheartj/ehaa254718440632227120]Search in Google Scholar
[6. ten Cate H. Thrombosis management in times of COVID-19 epidemy; a Dutch perspective. Thromb J. 2020;18:7.10.1186/s12959-020-00220-3716936932336956]Search in Google Scholar
[7. Conti P, Ronconi G, Caraffa A, et al. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents. 2020;34:327-331.]Search in Google Scholar
[8. Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020;18:1421-1424.10.1111/jth.14830726232432271988]Search in Google Scholar
[9. Qin C, Zhou L, Hu Z, et al. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71:762-768.10.1093/cid/ciaa248710812532161940]Search in Google Scholar
[10. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18:844-847.10.1111/jth.14768716650932073213]Search in Google Scholar
[11. Han H, Yang L, Liu R, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med. 2020;58:1116-1120.10.1515/cclm-2020-018832172226]Search in Google Scholar
[12. Helms J, Tacquard C, Severac F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46:1089-1098.10.1007/s00134-020-06062-x]Search in Google Scholar
[13. Barrett CD, Moore HB, Yaffe MB, Moore EE. ISTH interim guidance on recognition and management of coagulopathy in COVID-19: A comment. J Thromb Haemost. 2020;18:2060-2063.10.1111/jth.14860]Search in Google Scholar
[14. Schmidt M, Horvath-Puho E, Thomsen RW, Smeeth L, Sørensen HT. Acute infections and venous thromboembolism. J Intern Med. 2012;271:608-618.10.1111/j.1365-2796.2011.02473.x]Search in Google Scholar
[15. Iba T, Levy JH, Warkentin TE, et al. Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation. J Thromb Haemost. 2019;17:1989-1994.10.1111/jth.14578]Search in Google Scholar
[16. Beristain-Covarrubias N, Perez-Toledo M, Thomas MR, Henderson IR, Watson SP, Cunningham AF. Understanding Infection-Induced Thrombosis: Lessons Learned From Animal Models. Front Immunol. 2019;10:2569.10.3389/fimmu.2019.02569]Search in Google Scholar
[17. Semeraro N, Ammollo CT, Semeraro F, Colucci M. Sepsis, thrombosis and organ dysfunction. Thromb Res. 2012;129:290-295.10.1016/j.thromres.2011.10.013]Search in Google Scholar
[18. Fox SE, Akmatbekov A, Harbert JL, Li G, Quincy Brown J, Vander Heide RS. Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans. Lancet Respir Med. 2020;8:681-686.10.1016/S2213-2600(20)30243-5]Search in Google Scholar
[19. Spiezia L, Boscolo A, Poletto F, et al. COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure. Thromb Haemost. 2020;120:998-1000.10.1055/s-0040-171435032702757]Search in Google Scholar
[20. Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145-147.10.1016/j.thromres.2020.04.013714671432291094]Search in Google Scholar
[21. Kollias A, Kyriakoulis KG, Dimakakos E, Poulakou G, Stergiou GS, Syrigos K. Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action. Br J Haematol. 2020;189:846-847.10.1111/bjh.16727726453732304577]Search in Google Scholar
[22. Llitjos JF, Leclerc M, Chochois C, et al. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost. 2020;18:1743-1746.10.1111/jth.14869726477432320517]Search in Google Scholar
[23. Obi AT, Barnes GD, Wakefield TW, et al. Practical diagnosis and treatment of suspected venous thromboembolism during COVID-19 pandemic. J Vasc Surg Venous Lymphat Disord. 2020;8:526-534.10.1016/j.jvsv.2020.04.009716279432305585]Search in Google Scholar
[24. Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18:1094-1099.10.1111/jth.1481732220112]Search in Google Scholar